Literature DB >> 25957406

Stress-resistant Translation of Cathepsin L mRNA in Breast Cancer Progression.

Martina Tholen1, Julia Wolanski2, Britta Stolze2, Marco Chiabudini3, Mieczyslaw Gajda4, Peter Bronsert5, Elmar Stickeler6, Sabine Rospert3, Thomas Reinheckel7.   

Abstract

The cysteine protease cathepsin L (CTSL) is often thought to act as a tumor promoter by enhancing tumor progression and metastasis. This goes along with increased CTSL activity in various tumor entities; however, the mechanisms leading to high CTSL levels are incompletely understood. With the help of the polyoma middle T oncogene driven breast cancer mouse model expressing a human CTSL genomic transgene, we show that CTSL indeed promotes breast cancer metastasis to the lung. During tumor formation and progression high expression levels of CTSL are maintained by enduring translation of CTSL mRNA. Interestingly, human breast cancer specimens expressed the same pattern of 5' untranslated region (UTR) splice variants as the transgenic mice and the human cancer cell line MDA-MB 321. By polyribosome profiling of tumor tissues and human breast cancer cells, we observe an intrinsic resistance of CTSL to stress-induced shutdown of translation. This ability can be attributed to all 5' UTR variants of CTSL and is not dependent on a previously described internal ribosomal entry site motif. In conclusion, we provide in vivo functional evidence for overexpressed CTSL as a promoter of lung metastasis, whereas high CTSL levels are maintained during tumor progression due to stress-resistant mRNA translation.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  alternative splicing; breast cancer; cysteine protease; metastasis; translation control

Mesh:

Substances:

Year:  2015        PMID: 25957406      PMCID: PMC4505485          DOI: 10.1074/jbc.M114.624353

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  47 in total

1.  Impaired turnover of autophagolysosomes in cathepsin L deficiency.

Authors:  Julia Dennemärker; Tobias Lohmüller; Sebastian Müller; Stephanie Vargas Aguilar; Desmond J Tobin; Christoph Peters; Thomas Reinheckel
Journal:  Biol Chem       Date:  2010-08       Impact factor: 3.915

2.  Expression of cysteine peptidase cathepsin L and its inhibitors stefins A and B in relation to tumorigenicity of breast cancer cell lines.

Authors:  Irena Zajc; Natasa Sever; Ales Bervar; Tamara T Lah
Journal:  Cancer Lett       Date:  2002-12-10       Impact factor: 8.679

3.  Human cathepsin L rescues the neurodegeneration and lethality in cathepsin B/L double-deficient mice.

Authors:  Lisa Sevenich; Len A Pennacchio; Christoph Peters; Thomas Reinheckel
Journal:  Biol Chem       Date:  2006-07       Impact factor: 3.915

Review 4.  Proteolytic networks in cancer.

Authors:  Steven D Mason; Johanna A Joyce
Journal:  Trends Cell Biol       Date:  2011-01-12       Impact factor: 20.808

Review 5.  Cysteine cathepsins: multifunctional enzymes in cancer.

Authors:  Mona Mostafa Mohamed; Bonnie F Sloane
Journal:  Nat Rev Cancer       Date:  2006-10       Impact factor: 60.716

6.  Expression of cysteine protease cathepsin L is increased in endometrial cancer and correlates with expression of growth regulatory genes.

Authors:  Maciej Skrzypczak; Anette Springwald; Claus Lattrich; Julia Häring; Susanne Schüler; Olaf Ortmann; Oliver Treeck
Journal:  Cancer Invest       Date:  2012-03-27       Impact factor: 2.176

7.  Astrocyte-elevated gene-1 (AEG-1) induction by hypoxia and glucose deprivation in glioblastoma.

Authors:  Evan Noch; Markus Bookland; Kamel Khalili
Journal:  Cancer Biol Ther       Date:  2011-01-01       Impact factor: 4.742

8.  Cathepsin B but not cathepsins L or S contributes to the pathogenesis of Unverricht-Lundborg progressive myoclonus epilepsy (EPM1).

Authors:  Megan K Houseweart; Len A Pennacchio; Alex Vilaythong; Christoph Peters; Jeffrey L Noebels; Richard M Myers
Journal:  J Neurobiol       Date:  2003-09-15

Review 9.  Eukaryotic stress granules: the ins and outs of translation.

Authors:  J Ross Buchan; Roy Parker
Journal:  Mol Cell       Date:  2009-12-25       Impact factor: 17.970

Review 10.  The IRP/IRE system in vivo: insights from mouse models.

Authors:  Nicole Wilkinson; Kostas Pantopoulos
Journal:  Front Pharmacol       Date:  2014-07-28       Impact factor: 5.810

View more
  10 in total

1.  Cathepsin L upregulation-induced EMT phenotype is associated with the acquisition of cisplatin or paclitaxel resistance in A549 cells.

Authors:  Mei-Ling Han; Yi-Fan Zhao; Cai-Hong Tan; Ya-Jie Xiong; Wen-Juan Wang; Feng Wu; Yao Fei; Long Wang; Zhong-Qin Liang
Journal:  Acta Pharmacol Sin       Date:  2016-11-14       Impact factor: 6.150

Review 2.  Cysteine Cathepsins in Breast Cancer: Promising Targets for Fluorescence-Guided Surgery.

Authors:  Daan G J Linders; Okker D Bijlstra; Laura C Fallert; Denise E Hilling; Ethan Walker; Brian Straight; Taryn L March; A Rob P M Valentijn; Martin Pool; Jacobus Burggraaf; James P Basilion; Alexander L Vahrmeijer; Peter J K Kuppen
Journal:  Mol Imaging Biol       Date:  2022-08-24       Impact factor: 3.484

3.  A miRNA-200c/cathepsin L feedback loop determines paclitaxel resistance in human lung cancer A549 cells in vitro through regulating epithelial-mesenchymal transition.

Authors:  Yi-Fan Zhao; Mei-Ling Han; Ya-Jie Xiong; Long Wang; Yao Fei; Xiao Shen; Ying Zhu; Zhong-Qin Liang
Journal:  Acta Pharmacol Sin       Date:  2017-12-07       Impact factor: 6.150

4.  Cathepsin A inhibition attenuates myocardial infarction-induced heart failure on the functional and proteomic levels.

Authors:  Agnese Petrera; Johann Gassenhuber; Sven Ruf; Deepika Gunasekaran; Jennifer Esser; Jasmin Hasmik Shahinian; Thomas Hübschle; Hartmut Rütten; Thorsten Sadowski; Oliver Schilling
Journal:  J Transl Med       Date:  2016-05-31       Impact factor: 5.531

5.  Polyphenol-rich strawberry extract (PRSE) shows in vitro and in vivo biological activity against invasive breast cancer cells.

Authors:  Stefano Amatori; Luca Mazzoni; Josè Miguel Alvarez-Suarez; Francesca Giampieri; Massimiliano Gasparrini; Tamara Yuliett Forbes-Hernandez; Sadia Afrin; Alfredo Errico Provenzano; Giuseppe Persico; Bruno Mezzetti; Augusto Amici; Mirco Fanelli; Maurizio Battino
Journal:  Sci Rep       Date:  2016-08-08       Impact factor: 4.379

6.  Proteomic analysis of lung metastases in a murine breast cancer model reveals divergent influence of CTSB and CTSL overexpression.

Authors:  Florian Christoph Sigloch; Martina Tholen; Alejandro Gomez-Auli; Martin Lothar Biniossek; Thomas Reinheckel; Oliver Schilling
Journal:  J Cancer       Date:  2017-10-23       Impact factor: 4.207

Review 7.  Low-level lysosomal membrane permeabilization for limited release and sublethal functions of cathepsin proteases in the cytosol and nucleus.

Authors:  Thomas Reinheckel; Martina Tholen
Journal:  FEBS Open Bio       Date:  2022-03-09       Impact factor: 2.693

8.  Proteolysis-a characteristic of tumor-initiating cells in murine metastatic breast cancer.

Authors:  Larissa E Hillebrand; Fee Bengsch; Jochen Hochrein; Jan Hülsdünker; Julia Bender; Marie Follo; Hauke Busch; Melanie Boerries; Thomas Reinheckel
Journal:  Oncotarget       Date:  2016-09-06

9.  Cathepsin L interacts with CDK2-AP1 as a potential predictor of prognosis in patients with breast cancer.

Authors:  Zhan Wang; Zhen Xiang; Ting Zhu; Juan Chen; Mei-Zuo Zhong; Juan Huang; Kuan-Song Wang; Ling Li; Lun-Quan Sun; Wei-Bing Zhou
Journal:  Oncol Lett       Date:  2019-11-07       Impact factor: 2.967

Review 10.  Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition.

Authors:  Taylor C Brown; Narendra V Sankpal; William E Gillanders
Journal:  Biomolecules       Date:  2021-06-29
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.